From: Evaluation of treatment response in extrapulmonary tuberculosis in a low-resource setting
Total | Lymphadenitis | Pleuritis | Other sites of infectiona | ||||
---|---|---|---|---|---|---|---|
n = 126 | n = 67 | n = 31 | n = 28 | ||||
TB | Non-TB | TB | Non-TB | TB | Non-TB | ||
Characteristics | n = 34 | n = 33 | n = 20 | n = 11 | n = 10 | n = 18 | |
Female, n (%) | 56 (44%) | 17 (50%) | 14 (42%) | 7 (35%) | 5 (45%) | 5 (50%) | 8 (44%) |
Age, years, median [IQR] | 27 [8–41] | 27 [7–38] | 13 [7–49] | 32 [23–50] | 20 [6–41] | 27 [19–34] | 40 [26–50] |
Children (< 15 years), n (%) | 41 (33%) | 11 (32%) | 18 (55%) | 3 (15%) | 4 (36%) | 2 (20%) | 3 (17%) |
HIV status, n (%) | |||||||
HIV positive | 20 (16%) | 7 (21%) | 2 (6%) | 5 (25%) | 0 (−) | 2 (20%) | 4 (22%) |
HIV negative | 74 (59%) | 25 (74%) | 10 (30%) | 15 (75%) | 6 (55%) | 6 (60%) | 12 (67%) |
Unknown | 32 (25%) | 2 (6%) | 21 (64%) | 0 (−) | 5 (45%) | 2 (20%) | 2 (11%) |
Comorbidities, n (%) | |||||||
Diabetes | 4 (3%) | 0 (−) | 1 (3%) | 1 (5%) | 1 (9%) | 1 (10%) | 0 (−) |
Heart disease/HT | 12 (10%) | 2 (6%) | 3 (9%) | 0 (−) | 2 (18%) | 1 (10%) | 4 (24%) |
COPD/Asthma | 7 (6%) | 3 (9%) | 2 (6%) | 0 (−) | 1 (9%) | 1 (10%) | 0 (−) |
Outpatient, n (%) | 76 (60%) | 32 (94%) | 32 (97%) | 7 (35%) | 0 (−) | 3 (30%) | 2 (11%) |